AG
Artal Group Portfolio holdings
AUM
$930M
This Quarter Return
-8.07%
1 Year Return
-3.57%
3 Year Return
+157.23%
5 Year Return
+160.22%
10 Year Return
+1,359.85%
AUM
$1.73B
AUM Growth
+$1.73B
(-16%)
Cap. Flow
-$57.6M
Cap. Flow
% of AUM
-3.33%
Top 10 Holdings %
Top 10 Hldgs %
92.27%
Holding
87
New
10
Increased
3
Reduced
10
Closed
15
Top Buys
| 1 |
PCYC
PHARMACYCLICS INC
PCYC
|
$17.5M |
| 2 |
BioMarin Pharmaceuticals
BMRN
|
$10.6M |
| 3 |
General Motors
GM
|
$10.2M |
| 4 |
Alnylam Pharmaceuticals
ALNY
|
$8.04M |
| 5 |
Crown Castle
CCI
|
$7.34M |
Top Sells
| 1 |
AUXL
AUXILIUM PHARAMCEUTICALS INC
AUXL
|
$23.6M |
| 2 |
ACOR
Acorda Therapeutics, Inc.
ACOR
|
$11.5M |
| 3 |
Ford
F
|
$10.1M |
| 4 |
Terex
TEX
|
$9.24M |
| 5 |
Nektar Therapeutics
NKTR
|
$7.95M |
Sector Composition
| 1 | Consumer Discretionary | 55.72% |
| 2 | Healthcare | 35.95% |
| 3 | Financials | 1% |
| 4 | Real Estate | 0.93% |
| 5 | Materials | 0.36% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
WW
1
DELISTED
WW International
WW
| $947M | 33.95% | 28,749,089 | – | – |
|
2
Lexicon Pharmaceuticals
LXRX
$400M
| $456M | 16.36% | 253,372,135 | – | – |
|
|
FURX
3
DELISTED
FURIEX PHARMACEUTICALS INC COM STK (DE)
FURX
| $36.6M | 1.31% | 870,842 -100,209 | -10% | -$4.21M |
|
|
AUXL
4
DELISTED
AUXILIUM PHARAMCEUTICALS INC
AUXL
| $31.1M | 1.12% | 1,500,000 -1,137,200 | -43% | -$23.6M |
|
|
5
BioMarin Pharmaceuticals
BMRN
$11.2B
| $28.1M | 1.01% | 400,000 +150,000 | +60% | +$10.6M |
|
|
IMGN
6
DELISTED
Immunogen Inc
IMGN
| $24.2M | 0.87% | 1,650,000 | – | – |
|
|
ACOR
7
DELISTED
Acorda Therapeutics, Inc.
ACOR
| $20.4M | 0.73% | 700,000 -395,170 | -36% | -$11.5M |
|
|
8
Nektar Therapeutics
NKTR
$568M
| $18.2M | 0.65% | 1,600,000 -700,000 | -30% | -$7.95M |
|
|
PCYC
9
DELISTED
PHARMACYCLICS INC
PCYC
| $17.5M | 0.63% | +165,000 | New | +$17.5M |
|
10
Amgen
AMGN
$155B
| $17.1M | 0.61% | 150,000 | – | – |
|
|
ARRY
11
DELISTED
Array Biopharma Inc
ARRY
| $15M | 0.54% | 3,000,000 | – | – |
|
12
Xoma
XOMA
$392M
| $13.5M | 0.48% | 2,000,000 -500,000 | -20% | -$3.37M |
|
|
13
General Motors
GM
$55.8B
| $10.2M | 0.37% | +250,000 | New | +$10.2M |
|
14
Goldman Sachs
GS
$226B
| $8.86M | 0.32% | 50,000 +10,000 | +25% | +$1.77M |
|
15
Anywhere Real Estate
HOUS
$684M
| $8.66M | 0.31% | 175,000 -25,000 | -13% | -$1.24M |
|
|
16
Alnylam Pharmaceuticals
ALNY
$58.5B
| $8.04M | 0.29% | +125,000 | New | +$8.04M |
|
|
17
Crown Castle
CCI
$43.2B
| $7.34M | 0.26% | +100,000 | New | +$7.34M |
|
|
MTOR
18
DELISTED
MERITOR, Inc.
MTOR
| $6.78M | 0.24% | 650,000 -100,100 | -13% | -$1.04M |
|
|
AVNR
19
DELISTED
AVANIR PHARMACEUTICALS, INC CL A
AVNR
| $6.72M | 0.24% | 2,000,000 -1,100,000 | -35% | -$3.7M |
|
|
CERE
20
DELISTED
CERES, INC. COMMON STOCK NEW
CERE
| $5.79M | 0.21% | 4,192,167 | – | – |
|
21
MGIC Investment
MTG
$6.42B
| $4.22M | 0.15% | 500,000 -250,000 | -33% | -$2.11M |
|
|
ONIT
22
Onity Group Inc.
ONIT
$333M
| $4.16M | 0.15% | +75,000 | New | +$4.16M |
|
|
SPHS
23
DELISTED
Sophiris Bio, Inc.
SPHS
| $3.7M | 0.13% | 1,000,000 | – | – |
|
|
CPAC
24
Cementos Pacasmayo
CPAC
$581M
| $3.65M | 0.13% | 307,909 -71,700 | -19% | -$849K |
|
|
STML
25
DELISTED
Stemline Therapeutics, Inc.
STML
| $3.33M | 0.12% | +170,000 | New | +$3.33M |
|